HRA Pharma Rare Diseases funds online hub for Cushing’s Syndrome
Cushing’s Syndrome is rare and severe condition caused by prolonged high levels of cortisol in the blood
Read More
Tag: HRA Pharma Rare Diseases
- SolasCure trial shows faster healing with Aurase Wound Gel
- Gilead data show investigational HIV combination maintains viral suppression
- Verdiva Bio completes enrolment for phase 2b study of oral GLP‑1 candidate VRB‑101
- MHRA approves imlunestrant tosylate as new breast cancer treatment
- ACD440 granted orphan drug status in the EU
